Additionally, we previously discovered that elevated ATF4 action in β-cells during T2D impaired incretin receptor signaling via phosphodiesterase 4D (PDE4D)-mediated suppression of β-cell cAMP signaling (Lee et al., 2023). This evidence concerns the gene PDE4D and type 2 diabetes mellitus.